Fortekor may increase plasmacreatinine concentrations at the start of therapy.
Fortekor可能会增加在治疗开始血浆肌酐浓度。
2
Conculsion Childs-Pugh score and plasmacreatinine level were the risk factors influencing the therapeutic response to diuretic treatment of ascites in liver cirrhosis.
结论肝功能分级和血肌酐水平是影响肝硬化腹水利尿剂疗效的重要因素。
3
The blood pressure, nutritional status(ferrohemoglobin and serum albumin level) and renal function(plasmacreatinine level) were same in PCRT group compared with control group pretransplantation.